A late-stage study for a brain cancer vaccine has been discontinued, Celldex Therapeutics Inc. announced Monday. The drug manufacturing company said the results from a preplanned independent analysis found that the vaccine, Rintega, …
Hampton, NJ-based Celldex Therapeutics has become the latest beneficiary of that strategy through a deal today with Bristol-Myers Squibb. Celldex and Bristol-Myers said today that the two companies will work together to run a clinical …
The "Ewing Sarcoma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, …